Characteristics | HLA-A*2402 | p value | ||
---|---|---|---|---|
Matched (n = 50) | Unmatched (n = 46) | |||
Sex | ||||
Male | 25 | 24 | NS | |
Female | 25 | 22 | ||
Age | ||||
Mean | 64.3 | 63.4 | NS | |
Standard error | 10.9 | 8 | ||
Range | 36-82 | 38-77 | ||
Unresectable site | ||||
Liver | 27 | 35 | ||
Lung | 18 | 12 | ||
Dissemination | 5 | 4 | NS | |
Bone | 1 | 2 | ||
Lymphnode | 13 | 13 | ||
Other | 5 | 1 | ||
Number of unresectable sites | ||||
1 | 36 | 30 | ||
2 | 9 | 11 | ||
3 | 5 | 5 | ||
Resection of primary lesion | ||||
yes | 41 | 43 | ||
no | 9 | 3 | NS | |
Chemotherapy | ||||
FOLFOX | 48 | 45 | ||
XELOX | 2 | 1 | NS | |
(Bevacizumab) | 0 | (5) | ||
Primary minor site | ||||
Colon | 29 | 36 | 0.057 | |
Rectal | 21 | 10 |